4.8 Editorial Material

Dalbavancin: novel candidate for COVID-19 treatment

Journal

CELL RESEARCH
Volume 31, Issue 3, Pages 243-244

Publisher

SPRINGERNATURE
DOI: 10.1038/s41422-020-00459-5

Keywords

-

Categories

Funding

  1. Projekt DEAL

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available